Established 2003Preprogram 2019 ISGO |
|
| Agenda | |
| Thursday, October 10, 2019 | |
| 8:00AM 8:05AM | Presidential Inauguration Howard Hochster, MD; Ghassan Abou-Alfa, MD |
| 8:05AM 8:10AM | Introduction and Welcome From The President Ghassan Abou-Alfa, MD |
| Session 1: Pancreatic Cancer Chairpersons: Michael Choti, MD; Manisha Palta, MD |
|
| 8:10AM 8:25AM | Beyond FOLFIRINOX: Novel Strategies for Systemic Disease Davendra Sohal, MD Slides |
| 8:25AM 8:30AM | Q & A |
| 8:30AM 8:45AM | Role of Surgery in Locally Advanced Disease Following Neoadjuvant Therapy Matthew Katz, MD Slides |
| 8:45AM 8:50AM | Q & A |
| Debate: Neoadjuvant Chemoradiation vs Chemotherapy Alone for Borderline PDAC? | |
| 8:50AM 9:00AM | Chemoradiation:Manisha Palta, MD Slides |
| 9:00AM 9:10AM | Chemotherapy:Michael Choti, MD |
| 9:10AM 9:30AM | Panel Discussion Moderators: Michael Choti, MD; Manisha Palta, MD |
| 9:30AM 9:40AM | Case 1: Genomic Analysis and Management of Metastatic Pancreatic Cancer with an Actionable Aberration Michael Pishvaian, MD (Mentor); Samantha Armstrong, MD Slides |
| 9:40AM 9:50AM | Case 2: Local Recurrence After PD in a Patient Previously Treated with RT Mentor TBD; Fellow TBD Slides |
| 9:50AM 10:00AM | Case 3: Chemotherapy in Elderly Patient with Pancreatic Cancer Madappa Kundranda, MD (Mentor); Akshjot Puri, MD Slides |
| 10:00AM 10:15AM | Panel Discussion Michael Choti, MD; Manisha Palta, MD |
| 10:15AM 10:35AM | Break/Posters Available for Viewing |
| Session 2: Hepatobiliary Cancer Chairpersons: Ghassan Abou-Alfa, MD; Shishir K. Maithel, MD |
|
| 10:35AM 10:50AM | Systemic Therapies for Cholangiocarcinoma: One Size Fits All? Rachna T. Shroff, MD Slides |
| 10:50AM 10:55AM | Q & A |
| 10:55AM 11:10AM | Liver Transplant Options for Cholangiocarcinoma Keri Lunsford, MD Slides |
| 11:10AM 11:15AM | Q & A |
| Debate: The First Line Treatment for Non-Resectable, Non-Transplantable Liver Only HCC: | |
| 11:15AM 11:25AM | Systemic Therapy: Mark Yarchoan, MD Slides |
| 11:25AM 11:35AM | Liver-Directed Therapy: Michael Soulen, MD Slides |
| 11:35AM 11:50PM | Panel Discussion Moderators: Ghassan Abou-Alfa, MD; Shishir K. Maithel, MD |
| 11:50PM 12:00PM | Case 1: Systemic Therapy First-Line Treatment Madappa Kundranda, MD (Mentor); Akshjot Puri, MD Slides |
| 12:00PM 12:10PM | Case 2: Transplant versus Surgery for Early Disease Michael Choti, MD (Mentor); Rajesh Ramanathan, MD Slides |
| 12:10PM 12:35PM | Panel Discussion Moderators: Ghassan Abou-Alfa, MD; Shishir K. Maithel, MD |
| 12:35PM 2:00PM | Lunch/Satellite Symposia/Posters Available for viewing | Session 3: Esophageal/Gastric Cancer Chairpersons: David Ilson, MD, PhD; Weijing Sun, MD |
| Debate: FLOT versus CROSS- What is the Role of Radiotherapy | |
| 2:00PM 2:10PM | Chemotherapy Alone: Weijing Sun, MD Slides |
| 2:10PM 2:20PM | Chemotherapy + Radiotherapy: David Ilson, MD, PhD |
| 2:20PM 2:35PM | Panel Discussion Moderators: David Ilson, MD, PhD; Weijing Sun, MD |
| 2:35PM 2:50PM | What is the Role of Surgery in Gastric Cancer in the Setting of a Positive Cytology or Oligometastatic Disease? TBD |
| 2:50PM 2:55PM | Q & A |
| 2:55PM 3:10PM | Novel Targets and Immunotherapy Advances in Esophagogastric Adenocarcinoma? How do we Sequence New Immunotherapy Agents? Dan Catenacci, MD Slides |
| 3:10PM 3:15PM | Q & A |
| 3:15PM 3:25PM | Case 1: Long Term Responder to Chemotherapy or Immunotherapy David Ilson, MD, PhD (Mentor); Fellow TBD |
| 3:25PM 3:35PM | Case 2: Primary Chemoradiotherapy versus Chemoradiotherapy and Surgery: Esophageal Squamous Cancer Weijing Sun, MD (Mentor); Fellow TBD Slides |
| 3:35PM 3:50PM | Panel Discussion Chairpersons: David Ilson, MD, PhD; Weijing Sun, MD |
| 3:50PM | Meeting Adjourns |
| Friday, October 11, 2019 | |
| Session 4: Hot Topics in Gastrointestinal Oncology Chairpersons: Axel Grothey, MD; Howard Hochster, MD |
|
| 8:00AM 8:15AM | ESMO update Axel Grothey, MD Slides |
| 8:15AM 8:20AM | Q & A |
| 8:20AM 8:35AM | Where are we with Immunotherapy in GI Malignancies? Michael Overman, MD Slides |
| 8:35AM 8:40AM | Q & A |
| Debate: Can ctDNA as Marker of Minimal Residual Disease Used to Direct Adjuvant Therapy in Colon Cancer? | |
| 8:40AM 8:50AM | Pro:
Pashtoon Kasi, MD Slides |
| 8:50AM 9:00AM | Con: Al B. Benson III, MD Slides |
| 9:00AM 9:15AM | Panel Discussion Moderators: Axel Grothey, MD; Howard Hochster, MD |
| 9:15AM 9:30AM | The Coming Wave of Biosimilars: Are They Similar Enough? Howard Hochster, MD |
| 9:30AM 9:35AM | Q & A |
| Session 5: Localized/Adjuvant Colorectal Cancer Chairperson: Daniel Haller, MD; Stacey Stein, MD |
|
| 9:35AM 9:50AM | TNT in Rectal Cancer, Ready for Wider Adoption? Christopher Willett, MD Slides |
| 9:50AM 9:55AM | Q & A |
| 9:55AM 10:10AM | Optimal Treatment of Stage III Colon Cancer: What is the Big IDEA? TBD Slides |
| 10:10AM 10:15AM | Q & A |
| 10:15AM 10:25AM | Case 1: Sequencing of Therapy in a Patient with Rectal Cancer and Oligometastatic Disease Stacey Stein, MD (Mentor); Timil Patel, MD (Fellow) |
| 10:25AM 10:40AM | Panel Discussion Moderator: Daniel Haller, MD; Stacey Stein, MD |
| 10:40AM 11:00AM | Break/Posters Available for Viewing | Session 6: Neuroendocrine Tumors (NET) Chairpersons: Jonathan Strosberg, MD; Pamela Kunz, MD |
| 11:00AM 11:15AM | Novel Targeted Therapies Jennifer Chan, MD Slides |
| 11:15AM 11:20AM | Q & A |
| Debate: Unresectable Mesenteric Metastases: Should Tumors be Dissected off Mesenteric Vessels? | |
| 11:20AM 11:30AM | Pro: J. Philip Boudreaux, MD Slides |
| 11:30AM 11:40AM | Con: Amanda Laird, MD Slides |
| 11:40AM 12:00PM | Panel Discussion Moderators: Jonathan Strosberg, MD; Pamela Kunz, MD |
| 12:00PM 12:15PM | Patient Selection for PRRT: Who Should not be Treated? Lisa Bodei, MD |
| 12:15PM 12:20PM | Q & A |
| 12:20PM 12:30PM | Case 1: Carcinoid Syndrome Diarrhea, with Discussion about Differential DX of Diarrhea in Patients with NETs (Steatorrhea, Bile Acid Malabsorption, Short Gut) Jonathan Strosberg, MD (Mentor); Fellow TBD Slides |
| 12:30PM 12:40PM | Case 2: Selection of Therapy in Well-Differentiated G3 Pancreatic NET Pamela Kunz, MD (Mentor); Tanya Gupta, MD Slides |
| 12:40PM 12:55PM | Panel Discussion Moderator: Jonathan Strosberg, MD; Pamela Kunz, MD |
| 12:55PM 2:20PM | Lunch on own / Posters Available for Viewing |
| Session 7: Advanced Colon Cancer Chairperson: Al B. Benson III, MD; Michael Overman, MD |
|
| 2:20PM 2:35PM | Targeting Molecular Subsets in Metastatic Colorectal Cancer (dMMR, HER2, or BRAF V600E): Is it Time for Frontline Targeted Therapy? TBD Slides |
| 2:35PM 2:40PM | Q & A |
| 2:40PM 2:55PM | Management of Non-Resectable Oligo-Metastatic Colorectal Cancer: How Aggressive Should we be? Claudius Conrad, MD |
| 2:55PM 3:00PM | Q & A |
| 3:00PM 3:15PM | Management of MSS RAS-wt Metastatic Colorectal Cancer: Sidedness and Anti-EGFR Retreatment TBD Slides |
| 3:15PM 3:20PM | Q & A |
| 3:20PM 3:30PM | Case Presentation 1: Metastatic MSI Colon Cancer Al B. Benson III, MD (Mentor); Fellow TBD |
| 3:30PM 3:40PM | Case Presentation 2: Metastatic Colon Cancer Treatment with HEIPEC Howard Hochster, MD (Mentor); Fellow TBD |
| 3:40PM 4:00PM | Panel Discussion Moderators: Al B. Benson III, MD; Michael Overman, MD |
| 4:10PM 4:10PM | Closing Remarks Ghassan Abou-Alfa, MD |
| 4:10PM | Meeting Adjourns |
| ©2022 International Society of Gastrointestinal Oncology | info@isgio.org |